Frequently Asked Question
'Emideltide' is the name used for the substance in the FDA's 2026 compounding review paperwork; it refers to the same delta sleep-inducing peptide.1
Get notified
The vote is advisory. The decision that shapes access comes later - if and when the FDA opens a formal public comment window. Most people never hear it opened. Join the list and we'll tell you the instant it does, with step-by-step instructions to file a comment that counts.
